Skip to main content
Premium Trial:

Request an Annual Quote

Jennifer Skeen, Sue Beruti

BioTheranostics announced Jennifer Skeen has joined the firm as VP of clinical operations, while Sue Beruti joined the company as medical director. 

Skeen has 10 years of clinical laboratory operations management experience and was previously at Pathway Genomics, Asuragen, and Alvern Clinical Laboratories. Beruti was most recently director of pathology and medical affairs at Genoptix, where she headed the Biopharma Medical Division and medical affairs group. 

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more